Hugo Vicente Miranda

6PUBLICATIONS
17CO-AUTHORS
Neurology and neuromuscular diseasesCancer geneticsBiocatalysis and enzyme technologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 26, 2022
Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes.

Ana Chegão, Mariana Guarda, Bruno M Alexandre

|Apr 12, 2022
Dysmetabolism and Neurodegeneration: Trick or Treat?

Adriana M Capucho, Ana Chegão, Fátima O Martins

|Aug 16, 2021
Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases.

Luís Sousa, Mariana Guarda, Maria João Meneses

|Oct 24, 2017
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.

Hugo Vicente Miranda, Rafaela Cássio, Leonor Correia-Guedes

|Sep 26, 2017
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B.

Diana G Ferreira, Mariana Temido-Ferreira, Hugo Vicente Miranda

|Mar 04, 2017
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

Rita Machado de Oliveira, Hugo Vicente Miranda, Laetitia Francelle

Pageof 1

Frequent Collaborators

2 joint publications

Ana Chegão

1 joint publications

Sandra H Vaz

1 joint publications

Luísa V Lopes

1 joint publications

Tiago F Outeiro